At the Galien Forum, NPC President and CEO John O’Brien will join a panel discussion on “BioPharma Pressure Points: PBMs, Pricing, Access, and the Global Supply Chain.” The conference convenes top policy makers and leading industry executives who offer perspectives on pressing health challenges.
Thursday, November 7, 2024 | 9:05 AM - 10:05 AM ET
BioPharma Pressure Points: PBMs, Pricing, Access, and the Global Supply Chain
Chair:
Ezekiel J. Emanuel - Vice Provost for Global Initiatives; Co-Director, Healthcare Transformation Institute; Diane v.S. Levy and Robert M. Levy University Professor; Perelman School of Medicine and The Wharton School; University of Pennsylvania
Panelists:
- Ariel Katz - Co-founder and Chief Executive Officer, H1
- Daniel Mendelson - Chief Executive Officer, Morgan Health, JPMorgan Chase & Co.
- John M. O'Brien - President and Chief Executive Officer, National Pharmaceutical Council
- Janet Woodcock - Former Principal Deputy Commissioner, U.S. Food & Drug Administration